Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.

A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.

Computational method for screening drug compounds can help predict which ones will work best against tuberculosis or other diseases.

Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.

The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.

New analysis could help uncover potential drug targets for attention deficits and sensory hypersensitivity.

Unique survey of gene expression by cell type in humans and mice reveals several deficits affecting the most vulnerable neurons.

Seven researchers discuss the importance of COVID-19 research and pandemic preparedness, the value of teamwork, and the fragility of life.

In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.